Evidence map›Paper›PMID 41426863›Full record

ArticleCureus2025

Discrepant Biopsy and Serological Findings in Nephrotic Syndrome: A Case of Phospholipase A2 Receptor (PLA2R)-Positive Membranous Nephropathy Mimicking Post-infectious Glomerulonephritis.

Sally Hamad, Hussein Ali Kadhim Al-Iedani, Gagan Suresha, Noor Alwan, AbdulRahman Al-Mohammed

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sally HamadGeneral Medicine, Peterborough City Hospital, Peterborough, GBR.
Hussein Ali Kadhim Al-IedaniGeneral Medicine, Basrah Medical College, Basrah, IRQ.
Gagan SureshaGeneral Medicine, Peterborough City Hospital, Peterborough, GBR.
Noor AlwanGeneral Medicine, Peterborough City Hospital, Peterborough, GBR.
AbdulRahman Al-MohammedGeneral Medicine, Novosibirsk State University, Novosibirsk, RUS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-phospholipase A2 receptor (PLA2R) antibody testing has transformed the diagnosis of membranous nephropathy in adults with nephrotic syndrome. However, discrepancies between serological and histopathological findings can create significant diagnostic and therapeutic uncertainty. We report the case of a 72-year-old woman with heavy proteinuria, hypoalbuminaemia, and markedly elevated PLA2R antibodies, whose initial renal biopsy suggested a resolving post-infectious glomerulonephritis. Owing to persistent nephrotic syndrome, a second biopsy performed four weeks later revealed membranous nephropathy, prompting treatment with prednisolone and rituximab. Her course was complicated by steroid-refractory microscopic colitis, rapidly progressive vitiligo, severe fluid overload resistant to high-dose diuretics, and recurrent nocturnal desaturation, revealing previously undiagnosed chronic obstructive pulmonary disease. This case highlights the importance of repeat renal biopsy when serological and histological findings diverge and illustrates the challenges of delivering immunosuppression in patients with multiple comorbidities. Early multidisciplinary input was essential in establishing the diagnosis and planning treatment.

Indexed as

anti-phospholipase a2 receptor antibodiesbiopsymembranous nephropathymicroscopic colitisnephropathynephrotic syndromepla2rprimary membranous nephropathyrenal biopsyrituximab

Identifiers

PMID41426863
PMCPMC12717524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.